Ogino H - Search Results

1

Primary Pulmonary Synovial Sarcoma Showing a Prolonged Survival with Multimodality Therapy.

Ogino H, Hanibuchi M, Takizawa H, Sakiyama S, Sumitomo H, Iwamoto S, Ikushima H, Nakajima K, Nagahiro S, Yamago T, Toyoda Y, Bando Y, Nishioka Y. Ogino H, et al. Intern Med. 2016;55(4):381-7. doi: 10.2169/internalmedicine.55.5169. Epub 2016 Feb 15. Intern Med. 2016. PMID: 26875964 Free article.

2

The therapeutic efficacy of anti vascular endothelial growth factor antibody, bevacizumab, and pemetrexed against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice.

Li Q, Yano S, Ogino H, Wang W, Uehara H, Nishioka Y, Sone S. Li Q, et al. Among authors: ogino h. Clin Cancer Res. 2007 Oct 1;13(19):5918-25. doi: 10.1158/1078-0432.CCR-07-0501. Clin Cancer Res. 2007. PMID: 17908988

3

Follistatin suppresses the production of experimental multiple-organ metastasis by small cell lung cancer cells in natural killer cell-depleted SCID mice.

Ogino H, Yano S, Kakiuchi S, Muguruma H, Ikuta K, Hanibuchi M, Uehara H, Tsuchida K, Sugino H, Sone S. Ogino H, et al. Clin Cancer Res. 2008 Feb 1;14(3):660-7. doi: 10.1158/1078-0432.CCR-07-1221. Clin Cancer Res. 2008. PMID: 18245525

4

Novel dual targeting strategy with vandetanib induces tumor cell apoptosis and inhibits angiogenesis in malignant pleural mesothelioma cells expressing RET oncogenic rearrangement.

Ogino H, Yano S, Kakiuchi S, Yamada T, Ikuta K, Nakataki E, Goto H, Hanibuchi M, Nishioka Y, Ryan A, Sone S. Ogino H, et al. Cancer Lett. 2008 Jun 28;265(1):55-66. doi: 10.1016/j.canlet.2008.02.018. Epub 2008 Mar 24. Cancer Lett. 2008. PMID: 18364248

5

Lysophosphatidic acid stimulates the proliferation and motility of malignant pleural mesothelioma cells through lysophosphatidic acid receptors, LPA1 and LPA2.

Yamada T, Yano S, Ogino H, Ikuta K, Kakiuchi S, Hanibuchi M, Kanematsu T, Taniguchi T, Sekido Y, Sone S. Yamada T, et al. Among authors: ogino h. Cancer Sci. 2008 Aug;99(8):1603-10. doi: 10.1111/j.1349-7006.2008.00848.x. Cancer Sci. 2008. PMID: 18754873 Free PMC article.

6

Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor-activating mutations.

Yano S, Wang W, Li Q, Matsumoto K, Sakurama H, Nakamura T, Ogino H, Kakiuchi S, Hanibuchi M, Nishioka Y, Uehara H, Mitsudomi T, Yatabe Y, Nakamura T, Sone S. Yano S, et al. Among authors: ogino h. Cancer Res. 2008 Nov 15;68(22):9479-87. doi: 10.1158/0008-5472.CAN-08-1643. Cancer Res. 2008. PMID: 19010923

7

Intensification therapy with anti-parathyroid hormone-related protein antibody plus zoledronic acid for bone metastases of small cell lung cancer cells in severe combined immunodeficient mice.

Yamada T, Muguruma H, Yano S, Ikuta K, Ogino H, Kakiuchi S, Hanibuchi M, Uehara H, Nishioka Y, Sone S. Yamada T, et al. Among authors: ogino h. Mol Cancer Ther. 2009 Jan;8(1):119-26. doi: 10.1158/1535-7163.MCT-08-0874. Mol Cancer Ther. 2009. PMID: 19139120 Free article.

8

A bone metastasis model with osteolytic and osteoblastic properties of human lung cancer ACC-LC-319/bone2 in natural killer cell-depleted severe combined immunodeficient mice.

Otsuka S, Hanibuchi M, Ikuta K, Yano S, Goto H, Ogino H, Yamada T, Kakiuchi S, Nishioka Y, Takahashi T, Sone S. Otsuka S, et al. Among authors: ogino h. Oncol Res. 2009;17(11-12):581-91. doi: 10.3727/096504009789745511. Oncol Res. 2009. PMID: 19806789

9

E7080, a multi-tyrosine kinase inhibitor, suppresses the progression of malignant pleural mesothelioma with different proangiogenic cytokine production profiles.

Ikuta K, Yano S, Trung VT, Hanibuchi M, Goto H, Li Q, Wang W, Yamada T, Ogino H, Kakiuchi S, Uehara H, Sekido Y, Uenaka T, Nishioka Y, Sone S. Ikuta K, et al. Among authors: ogino h. Clin Cancer Res. 2009 Dec 1;15(23):7229-37. doi: 10.1158/1078-0432.CCR-09-1980. Epub 2009 Nov 24. Clin Cancer Res. 2009. PMID: 19934291

10

Expression of soluble vascular endothelial growth factor receptor-1 in human monocyte-derived mature dendritic cells contributes to their antiangiogenic property.

Kishuku M, Nishioka Y, Abe S, Kishi J, Ogino H, Aono Y, Azuma M, Kinoshita K, Batmunkh R, Makino H, Ranjan P, Minakuchi K, Sone S. Kishuku M, et al. Among authors: ogino h. J Immunol. 2009 Dec 15;183(12):8176-85. doi: 10.4049/jimmunol.0803849. J Immunol. 2009. PMID: 20007583

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

986 results

Search Page

Filters